Source: Eur Respir J 2014; 44: 1608-1615
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Hector Andreas, Kröner Carolin, Carevic Melanie, Bakele Martina, Rieber Nikolaus, Riethmüller Joachim, Griese Matthias, Zissel Gernot, Hartl Dominik. The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease. Eur Respir J 2014; 44: 1608-1615

Member's Comments

No comment yet.

Related content which might interest you: CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease Source: Eur Respir J 2015; 46: 395-404 Year: 2015 Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Interleukin-6 gene variants are associated with early Pseudomonas infection in cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 727s Year: 2005 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016 Year: 2017 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections Source: Eur Respir J 2012; 40: 227-238 Year: 2012 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017 Year: 2018 CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Airway iron and iron-regulatory cytokines in cystic fibrosis Source: Eur Respir J 2004; 24: 286-291 Year: 2004